These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19613840)

  • 1. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
    Bicanic T; Muzoora C; Brouwer AE; Meintjes G; Longley N; Taseera K; Rebe K; Loyse A; Jarvis J; Bekker LG; Wood R; Limmathurotsakul D; Chierakul W; Stepniewska K; White NJ; Jaffar S; Harrison TS
    Clin Infect Dis; 2009 Sep; 49(5):702-9. PubMed ID: 19613840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
    Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
    Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
    Jarvis JN; Meintjes G; Rebe K; Williams GN; Bicanic T; Williams A; Schutz C; Bekker LG; Wood R; Harrison TS
    AIDS; 2012 Jun; 26(9):1105-13. PubMed ID: 22421244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
    Muzoora CK; Kabanda T; Ortu G; Ssentamu J; Hearn P; Mwesigye J; Longley N; Jarvis JN; Jaffar S; Harrison TS
    J Infect; 2012 Jan; 64(1):76-81. PubMed ID: 22079502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.
    Beardsley J; Wolbers M; Kibengo FM; Ggayi AB; Kamali A; Cuc NT; Binh TQ; Chau NV; Farrar J; Merson L; Phuong L; Thwaites G; Van Kinh N; Thuy PT; Chierakul W; Siriboon S; Thiansukhon E; Onsanit S; Supphamongkholchaikul W; Chan AK; Heyderman R; Mwinjiwa E; van Oosterhout JJ; Imran D; Basri H; Mayxay M; Dance D; Phimmasone P; Rattanavong S; Lalloo DG; Day JN;
    N Engl J Med; 2016 Feb; 374(6):542-54. PubMed ID: 26863355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
    Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
    Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
    Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
    Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
    Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
    Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
    Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
    PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
    Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
    Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis.
    Dyal J; Akampurira A; Rhein J; Morawski BM; Kiggundu R; Nabeta HW; Musubire AK; Bahr NC; Williams DA; Bicanic T; Larsen RA; Meya DB; Boulware DR;
    Med Mycol; 2016 May; 54(4):361-9. PubMed ID: 26768372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.